Build:  8013-2

Date:  03-Feb-14

The NPLEx drug component precursor interface has received an update to more efficiently switch between production and test platforms.  In prior builds the only guaranteed method of moving from the test platform back to production was to exit POS and restart it.  This is no longer required.

If you have questions or suggestions about this information, contact support@paladinpos.com.